New fertility drug aims to boost IVF live birth rates
NCT ID NCT07216742
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether a daily injection of human menopausal gonadotropin (hMG) can help women with infertility develop more eggs and achieve a live birth during IVF. About 659 women aged 18-42 will receive either the hormone or a placebo. The main goal is to see if the treatment leads to more live births after transferring a single, genetically normal embryo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human menopausal gonadotropin (hMG) injection
- What this could lead to
- If successful, this could offer a more effective option for stimulating egg growth during IVF, potentially increasing the chance of a live birth.
- What could go wrong
- This is a phase 3 trial, but results may not apply to all infertility cases. The placebo group may also show success, and individual responses to hormones vary. Risks include ovarian hyperstimulation and multiple pregnancy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY (IVF PATIENTS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston IVF
RECRUITINGWaltham, Massachusetts, 02451, United States
Contact Email: •••••@•••••
-
CARE Fertility
RECRUITINGBedford, Texas, 76022, United States
-
Carolina Conceptions
RECRUITINGRaleigh, North Carolina, 27607, United States
Contact Email: •••••@•••••
-
Center for Reproductive Medicine
RECRUITINGWinter Park, Florida, 32789, United States
-
Fertility Centers of Illinois
RECRUITINGChicago, Illinois, 60610, United States
Contact Email: •••••@•••••
-
Fertility Institute of Hawaii
RECRUITINGHonolulu, Hawaii, 96814, United States
-
HRC Fertility
RECRUITINGEncino, California, 91436, United States
-
IVF Florida Reproductive Associates
RECRUITINGMargate, Florida, 33036, United States
-
Illume Fertility
RECRUITINGNorwalk, Connecticut, 06851, United States
-
Main Line Fertility
RECRUITINGBryn Mawr, Pennsylvania, 19010, United States
Contact Email: •••••@•••••
-
Pinnacle Fertility - Oregon
RECRUITINGPortland, Oregon, 97205, United States
-
Reach Fertility
RECRUITINGCharlotte, North Carolina, 28207, United States
Contact Email: •••••@•••••
-
Reproductive Associates of Delaware CCRM
NOT_YET_RECRUITINGNewark, Delaware, 19713, United States
-
Reproductive Biology Associates (RBA)
RECRUITINGAtlanta, Georgia, 30342, United States
-
Shady Grove Fertility - Rockville
RECRUITINGRockville, Maryland, 20850, United States
Contact Email: •••••@•••••
-
Shady Grove Houston
RECRUITINGWebster, Texas, 77598, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could body fat, not BMI, be the key to IVF success?
- A pill instead of a needle? new IVF trial tests drospirenone for women with low ovarian reserve
- Gentler embryo test could replace risky biopsy in IVF
- Can ultrasound stiffness tests predict fertility?
- 5,000 patients join study to uncover why fertility treatments fail
- New biobank aims to unlock secrets of male infertility